No PEM for COVID-19
Phase-Based Progress Estimates
Effectiveness
Safety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA
COVID-19+1 More
Virtual vs On Site Pulmonary Rehabilitation - OtherEligibility
18+
All Sexes
What conditions do you have?
Select
Eligibility
18+
All Sexes
What conditions do you have?
Select
Study Summary
The purpose of the study is to assess the physiologic, immunologic, and mental health effects of a rehabilitation program on patients with Long Haul COVID (LHC).
Eligible Conditions
- COVID-19
- Long Haul COVID or Post Acute Sequella of COVID - PASC (U09.9)
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 8 Secondary · Reporting Duration: 10 weeks
10 weeks
Change in Anxiety scores
Change in Depression scores
Change in General Quality of Life
Change in Sleep Quality Index
Change in a Dyspnea score.
Change in a Fatigue Score
Change in a Post Exertional Malaise score.
Change in aerobic capacity (Peak Oxygen Uptake, Anaerobic Threshold and Maximum Work rate) at 10 weeks after a comprehensive (normal intensity) pulmonary rehabilitation program.
Change in the Inflammatory Cytokines .
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
+ PEM
1 of 2
No PEM
1 of 2
Active Control
Experimental Treatment
40 Total Participants · 2 Treatment Groups
Primary Treatment: No PEM · No Placebo Group · N/A
No PEM
Other
Experimental Group · 1 Intervention: Virtual vs On Site Pulmonary Rehabilitation · Intervention Types: Other+ PEM
Other
ActiveComparator Group · 1 Intervention: Virtual vs On Site Pulmonary Rehabilitation · Intervention Types: OtherTrial Logistics
Trial Timeline
Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 10 weeks
Trial Background
William Stringer, MD
Principal Investigator
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Closest Location: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · Torrance, CA
2019First Recorded Clinical Trial
3 TrialsResearching COVID-19
4 CompletedClinical Trials
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “yes” if the following statements are true for you:You have been exposed to a patient with COVID-19 who has been in a long-haul flight.
You are able to perform a cardiopulmonary exercise test.
About The Reviewer
Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.
Popular Clinical Trials
Top Clinical Trials in Cities
Relevant Clinical Trials
Unbiased Results
We believe in providing patients with all the options.Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.Back to top
Conditions
Cancer Related
Treatments